Major histocompatibility complex complement (MHC) Bf alleles show trans species evolution between man and chimpanzee.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
04 10 2023
04 10 2023
Historique:
received:
25
11
2022
accepted:
04
09
2023
medline:
1
11
2023
pubmed:
5
10
2023
entrez:
4
10
2023
Statut:
epublish
Résumé
HLA and disease studies by using single allele statistics have been fruitless during the last 40 years for explaining association pathogenesis of the associated diseases.Other approaches are necessary to untangle this puzzle. We aim to revisit complement alleleism in humans and primates for both studying MHC and disease association to complotypes and extended MHC haplotypes in order to also explain the positive directional selection of maintaining immune response genes (complement, MHC adaptive and MHC non-specific genes) that keeps these three type of genes together in a short chromosome stretch (MHC) for million years. These genes may be linked to conjointly avoid microbes attack and autoimmunity. In the present paper, it is obtained a new Bf chimpanzee allele, provisionaly named Patr-Bf*A:01,that differs from other Bf alleles by having CTG at eleventh codon of exon 2 in order to start the newly suggested methodology and explain functional and evolutionary MHC obscure aspects. Exons 1 to 6 of Ba fragment of Bf gene were obtained from chimpanzee. This new chimpanzee Factor B allele (Patr-Bf*A:01) is to be identical to a infrequent human Bf allele (SNP rs641153); it stresses the strong evolutive pressure upon certain alleles that are trans specific. It also may apply to MHC extended haplotipes which may conjointly act to start an adequate immune response. It is the first time that a complement MHC class III allele is described to undergo trans species evolution,in contrast to class I and class II alleles which had already been reported . Allelism of complement factors are again proposed for studying MHC complement genes, complotypes, and extended MHC haplotypes which may be more informative that single MHC marker studies.
Identifiants
pubmed: 37794053
doi: 10.1038/s41598-023-42016-1
pii: 10.1038/s41598-023-42016-1
pmc: PMC10550962
doi:
Substances chimiques
Histocompatibility Antigens
0
Complement Factor B
EC 3.4.21.47
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16711Informations de copyright
© 2023. Springer Nature Limited.
Références
Nonaka, M. Evolution of the complement system. Subcell Biochem. 80, 31–43. https://doi.org/10.1007/978-94-017-8881-6_3 (2014).
doi: 10.1007/978-94-017-8881-6_3
pubmed: 24798006
Kolb, W. P. & MorrowPR, T. J. D. Ba and Bb fragments of factor B activation: Fragment production, biological activities, neoepitope expression and quantitation in clinical samples. Complement Inflamm. 6(3), 175–204. https://doi.org/10.1159/000463093 (1989).
doi: 10.1159/000463093
pubmed: 2472921
Arnaiz-Villena, A., Regueiro, J. R., Nieto-Cuartero, J. M., Ordoñez, A. & Serrano-Ríos, M. HLA and Complement (C4 and Bf) Allotypes in Type I and Type II Spanish Diabetics. In Diabetes: State of the Art (eds Baba, S. et al.) 39–48 (AcademicPress, 1984).
Martín-Villa, J. M., Arnaiz-Villena, A., Linares, L. & Gómez-Reino, J. Bf polymorphism in Spanish systemic lupus erythematosus patients of Spanish descent. Arthritis Rheum. 29, 932. https://doi.org/10.1002/art.1780290720 (1986).
doi: 10.1002/art.1780290720
pubmed: 3741506
Martín-Villa, J. M., Arnaiz-Villena, A., Linares, L. & Gómez-Reino, J. High BfF1 frequency in SLE patients with DPGN. Complement 3, 32 (1986).
Segurado, O. G., Gomez-Reino, J. & Arnaiz-Villena, A. Factor B activation in systemic lupus erythematosus. Arthritis Rheum. 33(10), 1598–1599. https://doi.org/10.1002/art.1780331024 (1990).
doi: 10.1002/art.1780331024
pubmed: 2222545
Rodríguez de Córdoba, S., Bootello, F. & Arnaiz-Villena, A. Bf polymorphism and its relationship with HLA antigens in a sample of Spanish population: High BfF1 frequencies. Tissue Antigens 17, 231. https://doi.org/10.1111/j.1399-0039.1981.tb00688.x (1981).
doi: 10.1111/j.1399-0039.1981.tb00688.x
Yang, Z. & Yu, C. Y. Organizations and gene duplications of the human and mouse MHC complement gene clusters. Exp. Clin. Immunogenet. 17(1), 1–17. https://doi.org/10.1159/0000191 (2000).
doi: 10.1159/0000191
pubmed: 10686478
Amiel, J. Study of the leukocyte phenotypes in Hodgkin’sdisease. In: Teraski PI (ed) Histocompatibility testing. Munksgaard, Denmark. (1967).
Arnaiz-Villena, A. et al. HLA-G: Function, polymorphisms and pathology. Int. J. Immunogenet. 48(2), 172–192. https://doi.org/10.1111/iji.12513 (2020).
doi: 10.1111/iji.12513
pubmed: 33001562
Arnaiz-Villena, A. et al. Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes. Cell. Mol. Life Sci. 79(8), 464. https://doi.org/10.1007/s00018-022-04491-z (2022).
doi: 10.1007/s00018-022-04491-z
pubmed: 35925520
pmcid: 9352621
Dawkins, R. L. et al. Disease associations with complotypes, supratypes and haplotypes. Immunol. Rev. 70, 5–22. https://doi.org/10.1111/j.1600-065x.1983.tb00707.x (1983).
doi: 10.1111/j.1600-065x.1983.tb00707.x
pubmed: 6832798
Martín-Villa, J. M. et al. HLA-G: Too much or too little? role in cancer and autoimmune disease. Front. Immunol. 13, 796054. https://doi.org/10.3389/fimmu.2022.796054 (2022).
doi: 10.3389/fimmu.2022.796054
pubmed: 35154112
pmcid: 8829012
Figueroa, F. The Primate Class Ill MHC Region Encoding Complement Components and Other Genes. In Molecular Biology and Evolution of Blood Group and MHC Antigens in Primates (eds Blancher, A. et al.) (Springer, 1997).
Müller, U., Stephan, D., Philippsen, P. & Steinmetz, M. Orientation and molecular map position of the complement genes in the mouse MHC. EMBO J6(2), 369–373. https://doi.org/10.1002/j.1460-2075.1987.tb04764.x (1987).
doi: 10.1002/j.1460-2075.1987.tb04764.x
Kaufman, J. et al. Gene organisation determines evolution of function in the chicken MHC. Immunol. Rev. 167, 101–117. https://doi.org/10.1111/j.1600-065x.1999.tb01385.x (1999).
doi: 10.1111/j.1600-065x.1999.tb01385.x
pubmed: 10319254
Miller, M. M. & Taylor, R. L. Jr. Brief review of the chicken major histocompatibility complex: The genes, their distribution on chromosome 16, and their contributions to disease resistance. Poult. Sci. 95, 375–392. https://doi.org/10.3382/ps/pev379 (2016).
doi: 10.3382/ps/pev379
pubmed: 26740135
pmcid: 4988538
Davrinche, C., Abbal, M. & Clerc, A. Molecular characterization of human complement factor B subtypes. Immunogenetics 32(5), 309–312. https://doi.org/10.1007/BF00211644 (1990).
doi: 10.1007/BF00211644
pubmed: 2249879
Campbell, R. D. The molecular genetics and polymorphism of C2 and factor B. Br. Med. Bull. 43(1), 37–49. https://doi.org/10.1093/oxfordjournals.bmb.a072175 (1987).
doi: 10.1093/oxfordjournals.bmb.a072175
pubmed: 3315100
Mayer, W. E., O’hUigin, C., Zaleska-Rutczynska, Z. & Klein, J. Trans-species origin of Mhc-DRB polymorphism in the chimpanzee. Immunogenetics 37, 12–23 (1992).
doi: 10.1007/BF00223540
pubmed: 1428008
Arnaiz-Villena, A. et al. Major histocompatibility complex allele persistence in Eurasia and America in the genus Carduelis (spinus) during million years. The Open Ornithology Journal 10, 92–104. https://doi.org/10.2174/1874453201710010092 (2017).
doi: 10.2174/1874453201710010092
Alper, C. A., Awdeh, Z. L. & Yunis, E. J. Complotypes, extended haplotypes, male segregation distortion, and disease markers. Hum. Immunol. 15(4), 366–373. https://doi.org/10.1016/0198-8859(86)90013-3 (1986).
doi: 10.1016/0198-8859(86)90013-3
pubmed: 3516938
Arnaiz-Villena, A. et al. DR, C4, and Bf allotypes in juvenile rheumatoid arthritis. Arthritis Rheum. 27(11), 1281–5128. https://doi.org/10.1002/art.1780271110 (1984).
doi: 10.1002/art.1780271110
pubmed: 6594139
Kerr, L. D., Adelsberg, B. R., Schulman, P. & Spiera, H. Factor B activation products in patients with systemic lupus erythematosus: a marker of severe disease activity. Arthritis Rheum. 32, 1406–1413. https://doi.org/10.1002/art.1780331024 (1989).
doi: 10.1002/art.1780331024
pubmed: 2818657